Tags: johnson andjohnson | intra-cellular

J&J to Buy Intra-Cellular Therapies for $14.6 Billion

J&J to Buy Intra-Cellular Therapies for $14.6 Billion
(AP)

Monday, 13 January 2025 08:03 AM EST

Johnson & Johnson said Monday it would buy drugmaker Intra-Cellular Therapies for about $14.6 billion, boosting its presence in the market for neurological disorder treatments.

J&J will buy all of Intra-Cellular's shares for $132 apiece, representing a 39% premium to their Friday closing price.

Shares of Intra-Cellular rose 35% to $128 in premarket trading.

The deal is the latest in a string of acquisitions by J&J as it looks to drive growth beyond 2025, when its blockbuster psoriasis drug Stelara could face competition from as many as six biosimilar versions in the U.S.

Last year, J&J acquired Numab's skin disorder drug for $1.25 billion, and spent $850 million to buy drug developer Proteologix. It also acquired heart device maker Shockwave Medical in a $13.1 billion deal, and took over V-Wave for $1.7 billion to help bolster growth at its medical device business.

© 2025 Thomson/Reuters. All rights reserved.


StreetTalk
Johnson & Johnson said Monday it would buy drugmaker Intra-Cellular Therapies for about $14.6 billion, boosting its presence in the market for neurological disorder treatments.
johnson andjohnson, intra-cellular
142
2025-03-13
Monday, 13 January 2025 08:03 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved